Cargando…

Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors

BACKGROUND: Despite the growth of psychedelic research, psychedelic-assisted group psychotherapy (PAGP) has received little attention in comparison to individual psychedelic-assisted psychotherapy models. METHODS: In this article, we aim to discuss the therapeutic potential of PAGP, as well as outli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponomarenko, Polina, Seragnoli, Federico, Calder, Abigail, Oehen, Peter, Hasler, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350738/
https://www.ncbi.nlm.nih.gov/pubmed/36855289
http://dx.doi.org/10.1177/02698811231155117
_version_ 1785074209703067648
author Ponomarenko, Polina
Seragnoli, Federico
Calder, Abigail
Oehen, Peter
Hasler, Gregor
author_facet Ponomarenko, Polina
Seragnoli, Federico
Calder, Abigail
Oehen, Peter
Hasler, Gregor
author_sort Ponomarenko, Polina
collection PubMed
description BACKGROUND: Despite the growth of psychedelic research, psychedelic-assisted group psychotherapy (PAGP) has received little attention in comparison to individual psychedelic-assisted psychotherapy models. METHODS: In this article, we aim to discuss the therapeutic potential of PAGP, as well as outline existing models and the challenges of this approach. Using Irvin Yalom’s 11 therapeutic factors of group therapy as a basic framework, we analyse current literature from clinical studies and neurobiological research relative to the topic of PAGP. RESULTS: We argue that combining psychedelic substances and group psychotherapy may prove beneficial for increasing group connectedness and interpersonal learning, potentially enhancing prosocial behaviour with direct opportunities to practice newly acquired knowledge about previously maladaptive behavioural patterns. Challenges regarding this approach include a more rigid therapy structure and potential loss of openness from patients, which may be ameliorated by adequate therapeutic training. CONCLUSION: We hope for this article to support clinical research on PAGP by presenting a therapeutic framework and outlining its mechanisms and challenges.
format Online
Article
Text
id pubmed-10350738
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-103507382023-07-18 Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors Ponomarenko, Polina Seragnoli, Federico Calder, Abigail Oehen, Peter Hasler, Gregor J Psychopharmacol Perspectives BACKGROUND: Despite the growth of psychedelic research, psychedelic-assisted group psychotherapy (PAGP) has received little attention in comparison to individual psychedelic-assisted psychotherapy models. METHODS: In this article, we aim to discuss the therapeutic potential of PAGP, as well as outline existing models and the challenges of this approach. Using Irvin Yalom’s 11 therapeutic factors of group therapy as a basic framework, we analyse current literature from clinical studies and neurobiological research relative to the topic of PAGP. RESULTS: We argue that combining psychedelic substances and group psychotherapy may prove beneficial for increasing group connectedness and interpersonal learning, potentially enhancing prosocial behaviour with direct opportunities to practice newly acquired knowledge about previously maladaptive behavioural patterns. Challenges regarding this approach include a more rigid therapy structure and potential loss of openness from patients, which may be ameliorated by adequate therapeutic training. CONCLUSION: We hope for this article to support clinical research on PAGP by presenting a therapeutic framework and outlining its mechanisms and challenges. SAGE Publications 2023-02-28 2023-07 /pmc/articles/PMC10350738/ /pubmed/36855289 http://dx.doi.org/10.1177/02698811231155117 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 Lficense (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Perspectives
Ponomarenko, Polina
Seragnoli, Federico
Calder, Abigail
Oehen, Peter
Hasler, Gregor
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
title Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
title_full Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
title_fullStr Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
title_full_unstemmed Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
title_short Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
title_sort can psychedelics enhance group psychotherapy? a discussion on the therapeutic factors
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350738/
https://www.ncbi.nlm.nih.gov/pubmed/36855289
http://dx.doi.org/10.1177/02698811231155117
work_keys_str_mv AT ponomarenkopolina canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors
AT seragnolifederico canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors
AT calderabigail canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors
AT oehenpeter canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors
AT haslergregor canpsychedelicsenhancegrouppsychotherapyadiscussiononthetherapeuticfactors